The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • How to interpret clinical trial results for Long COVID

    How to interpret clinical trial results for Long COVID

    Simon Spichak

    With no proven treatments or cures, many people with Long COVID are turning to off-label medications, supplements, and medical devices to treat their symptoms. There are numerous options — and some of them even have clinical trials underway or are reporting results. But even if one study suggests a treatment might work, another might contradict it. Read more…

Recent articles

  • Research updates, July 21
    Science
    Miles W. Griffis

    Research updates, July 21

  • National COVID-19 trends, July 21
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, July 21

  • Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers
    Commentary, International
    Whitney Fox

    Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peers

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersAbandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersWhitney Fox
What can professional athletes teach us about Long COVID and rest?What can professional athletes teach us about Long COVID and rest?Melanie Marich
How to interpret clinical trial results for Long COVIDHow to interpret clinical trial results for Long COVIDSimon Spichak
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
National COVID-19 trends, July 14National COVID-19 trends, July 14Betsy Ladyzhets

Policy & Advocacy

Science

  • A research building sitting on the bank of a river, with the Shionogi logo on the top of the building.
    January 21, 2025

    Research updates, January 21

  • A section of the AIDS quilt, featuring tributes to people who died of the disease. Each one is a colorful rectangle with the person's name, details about their life, and graphics. The section for activist Ryan White is black with green letters and a white candle.
    January 14, 2025

    Immune system damage from COVID-19 is different from HIV/AIDS — but the advocacy has parallels

  • Screenshot of slide from FNIH. "What has happened since the November 2024 RECOVER-TLC webinar?" December 2024: First wave of antiviral prioritization completed, scientific oversight committee (SOC) empaneled, newsletter issued, FNIH RECOVER-TLC website updated January 2025: Reached over 400 submissions to therapeutics portal, first SOC meeting, neurological prioritization group empaneled Upcoming: Antiviral prioritization wave 2, Immunomodulatory prioritization wave 1, Neurological agent prioritization wave 1, Host-targeted cardiovascular and metabolics prioritization groups empaneled Planned for February 2025: More prioritization, including waves 1 and 2 for different groups, second SOC meeting
    January 14, 2025

    Research updates, January 14

  • person holding clear glass bottle
    January 7, 2025

    Research updates, January 7

  • calculator and magnifying glass on survey sheets
    December 24, 2024

    Research updates, December 24

  • glass tubes with colorful liquids on table
    December 17, 2024

    Research updates, December 17

Previous Page
1 … 20 21 22 23 24 … 37
Next Page

Covid-19

  • August 6, 2024

    National Covid-19 trends, August 6

  • July 30, 2024

    National Covid-19 trends, July 30

  • July 29, 2024

    Olympics volunteers resign over lack of Covid-19 precautions

  • July 23, 2024

    Wastewater surveillance for Covid-19 keeps evolving. Here’s what you need to know.

  • A map of the United States color-coded in shades of orange and gray displaying SARS-CoV-2 Wastewater Viral Activity level as of July 18, 2024, where deeper tones correlate to higher viral activity and gray indicates “Insufficient,” or “No Data.” Viral activity is shown as “Very High” or “High” in 36 states, and “Moderate” in Ohio, Pennsylvania, Nebraska, Illinois, Oklahoma, Rhode Island, Michigan, New Jersey, Iowa, Mississippi, Indiana, South Dakota, and Wisconsin. No data is available for North Dakota, Puerto Rico, the U.S. Virgin Islands, or Guam. Text above the map reads "Very High" or "High" levels in 36 states. People’s CDC. Source: CDC.
    July 23, 2024

    National Covid-19 trends, July 23

  • July 16, 2024

    National Covid-19 trends, July 16

Previous Page
1 … 20 21 22 23 24 … 30
Next Page

Health

Commentary

  • October 10, 2025

    Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.

  • October 3, 2025

    Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.

  • September 30, 2025

    Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”

  • September 23, 2025

    Letter to the editors: Concerns about California’s right-to-mask bill

Previous Page
1 … 6 7 8 9 10 … 25
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...